Neurotech International Limited

A$0.02As of Sun 8 Nov 2026, 12:00 UTC
ASX:NTIHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (27.13%)
Div yield —
ROE (366.75%)
Biotechnology
Beta (5Y) (0.02)
PE TTM —
TSR TTM (5.88%)
Mkt cap A$25.86M
ROIC (231.77%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0204
27.38%
12.98%
Hold 2|4|6|1|4
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
(2.64%)
(4.97%)
(3.85%)
(1.91%)
Revenue$M
1.837
1.906
1.992
2.094
(2.73%)
3.17%
5.90%
10.91%
Peers (US$17.76M)
Cap (US$)
PE
22.69M
—
21.26M
—
17.74M
50.00x
Capital
TTM
5Y
10Y
Leveragex
1.010
0.044
0.028
EBIT/Intx
0.785
0.447
0.424
Own earn%
(5.40)
50.03
58.52
Sh yield%
36.20
28.91
27.86
Owners
Insiders/Inst%
0.27
80.59
Short interest%
5.03
SBC / revenue%
2.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
23–32
$1 testx
—
Incr. ROIC%
36